Human speak: Polycystic ovarian syndrome (PCOS) is one of the most common female reproductive disorders; affecting approximately 10% or more of women worldwide. PCOS is a big deal because it can lead to infertility and other health problems. The common symptoms associated with PCOS are irregular or no periods and anovulation (meaning you don’t ovulate, or ovulate rarely), increases in androgen hormones (like testosterone) and luteinizing hormone (which usually kicks off ovulation, but is persistently high in women with PCOS), and in some cases, insulin resistance and obesity. There is currently no “cure” for PCOS, just management of symptoms.
Su médico le medirá el nivel de insulina y glucosa en busca de diabetes o resistencia a la insulina (uso ineficiente de insulina por el cuerpo). Muchas mujeres con síndrome de ovario poliquístico tienen estos trastornos. Su médico quizá también le mida el nivel de colesterol y triglicéridos, ya que con frecuencia, son anormales en mujeres con el síndrome. Una vez que su médico haga un diagnóstico, decidirán juntos la mejor manera de tratar y controlar el problema.
Algunas chicas que padecen un síndrome de ovario poliquístico se deprimen; en estos casos, puede serles de ayuda hablar con un terapeuta u otro profesional de la salud mental. Hablar con otras adolescentes y con mujeres de más edad que padecen la misma afección es una buena forma de compartir información sobre su tratamiento y de obtener apoyo. Tu médico te puede recomendar un grupo de apoyo en tu localidad.
Metformin has been studied specifically in adolescent PCOS women. Metformin therapy for 10 mo decreased fasting serum insulin levels in obese girls with PCOS.The positive effects of metformin in adolescents wore off within 3 mo of medication discontinuation. Metformin in obese PCOS adolescents has shown improvements in IR by clamp studies, fasting measurements and OGTT after just 3 mo of therapy[76,77]. Other studies have found non-significant trends to improved IR by HOMA and OGTT-AUC in adolescent PCOS patients. Metformin has also been shown to effectively contribute to BMI reduction in PCOS adolescents.
Doc ask ko lng po na kung mag diet ang may pcos may posible po bang mabuntis?un po kc sabi ng obgyne d2 sa Japan..wala daw po gamot sa pcos mag diet lng daw po..irreg po kc ang mens ko at matab po ako..tapos po may mga bahid ng blood pero d ko naman po mens un..nag pa check up na po ako..hormomal imbalanced po ang sabi..kaya binigyan ako ng planovar pills para umaayos ang mens ko..mag paalaga din po ako sa doctor para mag kaanak..gus2 ko po payuhan nio po ako kung anong dapat gawin..salamat po
Once a diagnosis of PCOS is confirmed, it is imperative to assess women for CAD risk factors. Despite the many reasons women seek medical care for PCOS, the greatest long term risk for these women is CAD. This is generally not viewed or even recognized as a concern by women seeking care in the first place. The link between PCOS and CAD is multi-faceted. C-reactive protein (CRP) is higher in age matched PCOS women and is linked to BMI with some ethnic variation in this risk. The prevalence of MS in PCOS women is as high as 40% with increased prevalence of hypertension, dyslipidemia and abnormal glucose metabolism, all before age 30. PCOS women aged 20-40 already demonstrate poor vascular function measured by brachial artery vascular flow. No single blood test can predict or quantify this CAD risk. Although no standard recommendation for assessment of CAD risk factors exists, measurement of glucose metabolism, blood pressure screening, lipid screening and carotid intimal media thickness measurements have been suggested.
High levels of masculinizing hormones: Known as hyperandrogenism, the most common signs are acne and hirsutism (male pattern of hair growth, such as on the chin or chest), but it may produce hypermenorrhea (heavy and prolonged menstrual periods), androgenic alopecia (increased hair thinning or diffuse hair loss), or other symptoms. Approximately three-quarters of women with PCOS (by the diagnostic criteria of NIH/NICHD 1990) have evidence of hyperandrogenemia.
The genetic component appears to be inherited in an autosomal dominant fashion with high genetic penetrance but variable expressivity in females; this means that each child has a 50% chance of inheriting the predisposing genetic variant(s) from a parent, and, if a daughter receives the variant(s), the daughter will have the disease to some extent. The genetic variant(s) can be inherited from either the father or the mother, and can be passed along to both sons (who may be asymptomatic carriers or may have symptoms such as early baldness and/or excessive hair) and daughters, who will show signs of PCOS. The phenotype appears to manifest itself at least partially via heightened androgen levels secreted by ovarian follicle theca cells from women with the allele. The exact gene affected has not yet been identified. In rare instances, single-gene mutations can give rise to the phenotype of the syndrome. Current understanding of the pathogenesis of the syndrome suggests, however, that it is a complex multigenic disorder.
The routine use of OGTT is advocated by some in all PCOS women. In teenagers, abnormalities in glucose metabolism manifest prior to dyslipidemia, suggesting that assessment of glucose metabolism is even more important in younger women. DM is diagnosed by an 8 h fasting plasma glucose ≥ 126 mg/dL, 2 h glucose value ≥ 200 mg/dL after oral glucose tolerance test (OGTT) or random glucose ≥ 200 mg/dL with symptoms of DM confirmed by either fasting plasma glucose or OGTT. Hemoglobin AIC > 6.5% may also be issued to diagnose DM. Impaired glucose tolerance (IGT) is defined by a 2 h cutoff of 140-200 mg/dL on OGTT.The prevalence of IGT in obese adolescents is surprisingly as high as 15%.
This information is not designed to replace a physician's independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions. Vertical Health & EndocrineWeb do not provide medical advice, diagnosis or treatment. Use of this website is conditional upon your acceptance of our user agreement.
Serum (blood) levels of androgens (hormones associated with male development), including androstenedione and testosterone may be elevated. Dehydroepiandrosterone sulfate levels above 700–800 µg/dL are highly suggestive of adrenal dysfunction because DHEA-S is made exclusively by the adrenal glands. The free testosterone level is thought to be the best measure, with ~60% of PCOS patients demonstrating supranormal levels. The Free androgen index (FAI) of the ratio of testosterone to sex hormone-binding globulin (SHBG) is high and is meant to be a predictor of free testosterone, but is a poor parameter for this and is no better than testosterone alone as a marker for PCOS, possibly because FAI is correlated with the degree of obesity.
Aunque el síndrome de ovario poliquístico (que antes se llamaba "síndrome de Stein-Leventhal") se identificó por primera vez en la década de los años treinta del siglo XX, los médicos todavía no conocen sus causas con certeza. Las investigaciones sugieren que puede estar relacionado con un aumento de la fabricación de insulina en el cuerpo. Las mujeres con síndrome de ovario poliquístico es posible que produzcan demasiada insulina, lo que estimula a sus ovarios a liberar un exceso de hormonas masculinas. El síndrome de ovario poliquístico parece darse por familias, de modo que si lo padece alguna pariente tuya, tú podrías ser proclive a desarrollarlo.
just saying, sometimes on payday i head to the drugstore and buy one or two nyx lip products along with other stuff and they're just under 10 euro a pop here. Like on payday I feel pretty dodgy for paying 30 euro for like three lip products. I imagine even her dad would feel weird about spending that much money on something so stupid when he could get her groceries or actual useful bathing products instead.
Hi Dokbru, simula po kasi nag ka hyperacidity ako last october hindi n naman po nag regular ang menstruation ko. Minsan isang buwan konti lang lalabas n dugo n medyo parang putik pa ang kulay nya s ngaun po mag 2months n po akong d dinadatnan. Di naman po ako mabuntis kasi wala po dito asawa ko.. Nung high school pa po kc ako nkaranas na ako ng di nireregla at 5months po un .. Anu po pwede kung gawin?
Second-line therapy, when clomiphene citrate fails to lead to pregnancy, is either exogenous gonadotropins or laparoscopic ovarian surgery. [2, 3] If gonadotropins are used, a low-dose regimen is recommended,  and patients must be monitored with ultrasonography and laboratory studies.  Note that gonadotropin therapy is expensive and is associated with an increased risk of multiple pregnancy and ovarian hyperstimulation syndrome. 
Polycystic ovary syndrome is the most common endocrinopathy among reproductive-aged women in the United States, affecting approximately 7% of female patients. Although the pathophysiology of the syndrome is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factor. Metabolic syndrome is twice as common in patients with polycystic ovary syndrome compared with the general population, and patients with polycystic ovary syndrome are four times more likely than the general population to develop type 2 diabetes mellitus. Patient presentation is variable, ranging from asymptomatic to having multiple gynecologic, dermatologic, or metabolic manifestations. Guidelines from the Endocrine Society recommend using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings—hyperandrogenism, ovulatory dysfunction, and polycystic ovaries—plus the exclusion of other diagnoses that could result in hyperandrogenism or ovulatory dysfunction. It is reasonable to delay evaluation for polycystic ovary syndrome in adolescent patients until two years after menarche. For this age group, it is also recommended that all three Rotterdam criteria be met before the diagnosis is made. Patients who have marked virilization or rapid onset of symptoms require immediate evaluation for a potential androgen-secreting tumor. Treatment of polycystic ovary syndrome is individualized based on the patient's presentation and desire for pregnancy. For patients who are overweight, weight loss is recommended. Clomiphene and letrozole are first-line medications for infertility. Metformin is the first-line medication for metabolic manifestations, such as hyperglycemia. Hormonal contraceptives are first-line therapy for irregular menses and dermatologic manifestations.